83328 |
JOURNAL OF TRANSLATIONAL MEDICINE |
Loss of IL-10 secretion by regulatory B lymphocytes in multiple sclerosis patients |
2011-11-23 |
10.1186/1479-5876-9-s2-p25 |
Michel Laure, Degauque Nicolas, Garcia Alexandra, Salou Marion, Ngono Annie Elong, Soulillou Jean-Paul, Laplaud David, Brouard Sophie |
83327 |
JOURNAL OF TRANSLATIONAL MEDICINE |
The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways |
2011-11-23 |
10.1186/1479-5876-9-s2-p22 |
Glaichenhaus Nicolas, Julia Valérie |
83326 |
JOURNAL OF TRANSLATIONAL MEDICINE |
Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis |
2011-11-23 |
10.1186/1479-5876-9-s2-p14 |
Balak Deepak MW, Hengstman Gerald JD, Hupperts Raymond, Thio H Bing |
83325 |
JOURNAL OF TRANSLATIONAL MEDICINE |
Anti-inflammatory and immune modulatory properties of mesenchymal stromal cells |
2011-11-23 |
10.1186/1479-5876-9-s2-i15 |
Fibbe Willem E |
83324 |
JOURNAL OF TRANSLATIONAL MEDICINE |
Immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10 |
2011-11-23 |
10.1186/1479-5876-9-s2-p1 |
Ambarus Carmen, Geurts-van Bon Lenny, Wenink Mark, Tak Paul Peter, Radstake Timothy, Baeten Dominique |
83323 |
JOURNAL OF TRANSLATIONAL MEDICINE |
Case series: rituximab in the treatment of refractory sight-threatening scleritis |
2011-11-23 |
10.1186/1479-5876-9-s2-p12 |
van Bilsen Kiki, van Hagen P Martin, Missotten Tom, Baarsma Seerp G, Kuijpers Robert W, van Laar Jan AM |
83322 |
JOURNAL OF TRANSLATIONAL MEDICINE |
Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis |
2011-11-23 |
10.1186/1479-5876-9-s2-p19 |
Pers Yves-Marie, Louis-Plence Pascale, Portales Pierre, Quentin Julie, Fabre Sylvie, Eliaou Jean-François, Jorgensen Christian |
83321 |
JOURNAL OF TRANSLATIONAL MEDICINE |
Immune-mediated muscle wasting and cell survival - the tale of a curious gene |
2011-11-23 |
10.1186/1479-5876-9-s2-i8 |
Ross James A |
83320 |
ONCOLOGY REPORTS |
EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy |
2011-11-23 |
10.3892/or.2011.1559 |
Lin Dianjie |
83319 |
JOURNAL OF TRANSLATIONAL MEDICINE |
Breakdown of antimicrobial host defense barrier as trigger of chronic inflammatory bowel diseases |
2011-11-23 |
10.1186/1479-5876-9-s2-i14 |
Wehkamp Jan |